Annual report pursuant to Section 13 and 15(d)

Statements of Operations

v3.21.1
Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Statements of Operations    
Grant revenue $ 428,129 $ 0
Cost of grant revenue 428,129 0
Gross profit 0 0
Operating expenses:    
Research and development 1,720,893 1,050,151
General and administrative 2,347,089 2,065,112
Total operating expenses 4,067,982 3,115,263
Loss from continuing operations before interest (4,067,982) (3,115,263)
Other expenses:    
Interest expense, net 5,049 4,267
Warrant inducement expense 3,720,866 0
Total other expenses 3,725,915 4,267
Loss from continuing operations (7,793,897) (3,119,530)
Loss from discontinued operations 0 (799,025)
Loss on sale of discontinued operations 0 9,107
Net loss $ (7,793,897) $ (3,927,662)
Loss from continuing operations per share - basic and fully diluted (in dollars per share) $ (2.20) $ (1.89)
Loss from discontinued operations per share - basic and fully diluted (in dollars per share) 0.00 (0.49)
Net loss per share - basic and fully diluted $ (2.20) $ (2.38)
Weighted average number of shares outstanding - basic and fully diluted (in shares) 3,539,217 1,653,996